Your browser doesn't support javascript.
loading
Statin adherence in patients with high cardiovascular risk: a cross-sectional study.
Doganer, Yusuf Cetin; Aydogan, Umit; Kaplan, Umit; Gormel, Suat; Rohrer, James Edwin; Yuksel, Uygar Cagdas.
Afiliação
  • Doganer YC; Department of Family Medicine, University of Health Sciences, Gulhane School of Medicine, Turkey.
  • Aydogan U; Department of Family Medicine, University of Health Sciences, Gulhane School of Medicine, Turkey.
  • Kaplan U; Military Health Services, Ministry of National Defence, Turkey.
  • Gormel S; Department of Cardiology, University of Health Sciences, Gulhane Training and Research Hospital, Turkey.
  • Rohrer JE; College of Health Sciences and Public Policy, Walden University, School of Health Sciences, Minneapolis, MN, USA.
  • Yuksel UC; Department of Cardiology, University of Health Sciences, Gulhane Training and Research Hospital, Turkey.
Postgrad Med ; 135(4): 361-369, 2023 May.
Article em En | MEDLINE | ID: mdl-36345979
ABSTRACT

OBJECTIVES:

Statin adherence is an essential problem although lifetime medication is recommended especially in patients with high cardiovascular risk. The importance of perceived risk as a predictor of adherence among cardiology patients has not been fully explored. This study aimed to test the importance of perceived risk as a predictor of statin adherence amongst hypercholesterolemic patients to identify predictors associated with poor adherence.

METHODS:

This cross-sectional study was conducted at cardiology outpatient clinics of the University hospital in Ankara, Turkey. A total of 327 consecutive patients with high CV risk were recruited. Self-reported Morisky Green Levine Medication Adherence Scale was used to assess statin adherence.

RESULTS:

Of the patients studied, 34.5% had concerns about side effects. Also, the mean age was 63.85 ± 11.29 years, 66.1% were men, 32.4% applied non-drug alternative therapies, 53.2% had a Mediterranean-style diet and 20.8% checked their lipid values irregularly. Participants reported 50.2% high, 30% moderate, and 19.9% low statin medication adherence. Low-density lipoprotein cholesterol (LDL-C), Total Cholesterol (TC), Triglyceride (TG) and high-density lipoprotein (HDL) control rates were 44.6%, 74.3%, 61.5% and 41.6%. On multiple logistic regression, concern about side effects was associated with a statistically significant quadruple elevation of odds of non-adherence. Also, being male, former smokers, not having complementary interventions, having regular visits, being educated for more than 5 years, having low depressive symptom scores, living in a rural, being never or former smokers, employee were significant predictors of high medication adherence scores.

CONCLUSION:

Approximately half of the patients reported high medication adherence. Proper strategies to improve adherence would include patient education efforts focused on patients with concerns about side effects and those who are female, less educated, current smokers, interested in complementary interventions, have irregular follow-up visits, and have depressive symptoms. Brief medication adherence scales may facilitate the assessment of patients' adherence.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Inibidores de Hidroximetilglutaril-CoA Redutases Idioma: En Ano de publicação: 2023 Tipo de documento: Article